Leiras offers drug delivery technology:
This article was originally published in Clinica
Finnish company Leiras is to offer to biotechnology and pharmaceutical companies its proprietary polymer-based drug delivery technology, known as Delvivo. The company, which is part of the German group Schering, says its technology enables active drug ingredients to be released over a long time and at an even rate into the body. There is also the possibility that Leiras would market some products emerging from any deals. The technology is also the basis of Schering's intrauterine system, Mirena, which is sold in 48 countries worldwide, including the US.